GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28492
Submission : 2014-07-21
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31345
Submission : 2017-01-04
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39457
Submission : 2024-02-06
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32383
Submission : 2017-12-27
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34198
Submission : 2020-04-03
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32545
Submission : 2019-03-04
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : SOLIFENACIN SUCCINATE
Dosage Form : TABLET; ORAL
Application Number : 209818
Country : US
Patented : No
Drug : VALGANCICLOVIR HYDROCHLORIDE
Dosage Form : FOR SOLUTION; ORAL
Application Number : 213306
Country : US
Patented : No
Drug : LIDOCAINE
Dosage Form : PATCH; TOPICAL
Application Number : 200675
Country : US
Patented : No
Drug : DABIGATRAN ETEXILATE MESYLATE
Dosage Form : CAPSULE; ORAL
Application Number : 208040
Country : US
Patented : No
Drug : ASPIRIN AND DIPYRIDAMOLE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 206392
Country : US
Patented : No
Drug : TEMOZOLOMIDE
Dosage Form : CAPSULE; ORAL
Application Number : 203490
Country : US
Patented : No
Drug : ARIPIPRAZOLE
Dosage Form : TABLET; ORAL
Application Number : 78583
Country : US
Patented : No
Drug : TEMOZOLOMIDE
Dosage Form : CAPSULE; ORAL
Application Number : 78879
Country : US
Patented : No
Drug : ASPIRIN AND DIPYRIDAMOLE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 78804
Country : US
Patented : No
Drug : ASPIRIN AND DIPYRIDAMOLE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 204552
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
REF. STANDARDS & IMPURITIES